Leadership Overview
Resolian has 4 executives leading key functions including strategy, finance, and regional operations.
Driven by a commitment to scientific advancement, Resolian leverages deep expertise from Alliance Pharma and Drug Development Solutions to deliver unparalleled therapeutic solutions globally.
Driven by a commitment to scientific advancement, Resolian leverages deep expertise from Alliance Pharma and Drug Development Solutions to deliver unparalleled therapeutic solutions globally.
Leadership Roles at Resolian
Robert Stachlewitz - Chief Executive Officer
Robert Stachlewitz, the Chief Executive Officer at Resolian, directs the overarching corporate strategy and operational framework. Overseeing all functional departments, Stachlewitz ensures seamless integration of expertise from Alliance Pharma and Drug Development Solutions to advance therapeutic modalities. This leadership position involves driving innovation across the organization, fostering a culture of scientific excellence, and guiding the company's expansion into new markets. By aligning departmental objectives with the company's mission, Robert Stachlewitz champions the delivery of world-class scientific solutions. The Chief Executive Officer's responsibilities extend to stakeholder relations, investor communications, and long-term business development, solidifying Resolian's position as a leader in R&D services. Strategic planning for global operations falls under this executive's purview, ensuring efficient resource allocation and maximum impact.
Alexander Abramov - Chief Financial Officer
Alexander Abramov, the Chief Financial Officer at Resolian, manages all financial operations and fiscal strategy. Overseeing budgeting, forecasting, and financial reporting, Abramov ensures robust financial health and compliance across the organization. This role involves strategic capital allocation, risk management, and optimizing financial performance to support the company's growth objectives. Alexander Abramov collaborates closely with other executive leaders to align financial planning with operational initiatives, particularly in integrating the financial systems of Alliance Pharma and Drug Development Solutions. The Chief Financial Officer's oversight extends to investment analysis and securing funding for research and development projects, directly impacting the company's ability to deliver cutting-edge therapeutic solutions. Ensuring fiscal discipline and transparency are paramount to Abramov's leadership.
Laixin Wang - President, Site (China)
Laixin Wang, the President, Site (China) at Resolian, spearheads operations and strategic development within the China region. Overseeing all site-specific functions, Wang ensures the effective implementation of Resolian's scientific solutions and therapeutic modalities in the Chinese market. This leadership role involves managing local teams, fostering key partnerships, and driving business growth in alignment with global corporate objectives. Laixin Wang's responsibilities include ensuring operational efficiency, regulatory compliance, and the seamless integration of local expertise with the broader company framework. The President, Site (China) plays a critical part in expanding Resolian's reach and impact, leveraging regional insights to enhance service delivery. Wang's focus remains on cultivating a high-performing environment that supports innovation and client success.
Jason Wang - President, Site (Australia)
Jason Wang, the President, Site (Australia) at Resolian, leads all operational activities and strategic initiatives for the Australian site. Overseeing the execution of world-class scientific solutions, Wang ensures that Resolian's expertise in therapeutic modalities is effectively deployed across the region. This executive position involves managing local resources, cultivating strategic alliances, and driving market penetration to achieve ambitious growth targets. Jason Wang's mandate includes maintaining high standards of operational excellence, adhering to all regulatory requirements, and fostering a collaborative environment that integrates the Australian operations with the global company vision. The President, Site (Australia) is instrumental in extending Resolian's influence and delivering exceptional value to clients in the Australian market. Wang's leadership focuses on sustainable development and client satisfaction.
Explore Leadership Teams in Business Services
IQVIA is a global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find solutions for their patients. IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing the information that helps their customers drive human health outcomes forward. IQVIAs insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. IQVIA has dual headquarters in Danbury Connecticut and Durham, North Carolina.
Company Leadership JR
AF
AM
NeoGenomics, Inc together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics is headquartered in Fort Myers, Florida.
Company Leadership DO
Mercedes-Benz Research & Development India (MBRDI), headquartered in Karnataka, India and founded in 1996, is a research and development center for Daimler.
Company Leadership
PS
HP
DE
Genewiz is an R&D genomics services company providing Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next-generation sequencing, bioinformatics, and GLP regulatory services. The company was founded in 1999 and is headquartered in South Plainfield, New Jersey.
Company Leadership
LL
JD
SV
Frequently Asked Questions Regarding Resolian Top Executives and Leadership Team
